Barcelona is hosting the third edition of the Wine & Culinary International Forum today, a biennial international conference dedicated to food and wine pairing promoted by Bodegas Torres. Over 250 professionals, including sommeliers, restaurant owners, distributors and journalists from almost 20 different countries, participated in the event. Celebrated in the Palau de Congressos de Catalunya, it provided a forum in which to reflect and discuss the complementary relationship between wine and food under the heading “Wine and World Cuisines.”
The president of Bodegas Torres, Miguel A. Torres, opened the event, which featured talks, tastings and culinary demonstrations by a total of 20 national and international experts who are highly regarded in their fields. Among them, Josep Roca, sommelier at El Celler de Can Roca; the award winning wine-writer and journalist Sarah Jane Evans MW, an expert in Spanish wines as well as the former Chairman of the Institute of Masters of Wine; the prestigious French enologist Pascal Chatonnet, one of the leading researchers into the microbiological factors involved in the interaction between wine and oak; Canadian researcher François Chartier, a pioneer in the aromatic science of molecular food matching since 2004 and author of Taste Buds and Molecules, world’s best innovative food 2010; the renowned French wine critic Michel Bettane; and the endocrinologist Dr. Francisco Tinahones, a researcher at the University of Malaga.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7948051-torres-wine-culinary-international-forum/
Bayer and National 4-H Council amplified their commitment to the future of our rapidly expanding global population by launching a new effort to grow the pipeline of tomorrow’s innovators, starting now. The two organizations announced today a nationwide collaboration, Science Matters, which will address the need for an enhanced STEM (science, technology, engineering and math) workforce by planting a love of scientific exploration in thousands of youth in urban and rural areas across the country.
Science Matters will leverage Bayer’s more than 150 years of scientific breakthroughs and 4-H’s century of hands-on learning to equip more than 25,000 youth with tools and support they need to deepen their understanding of science.
To view the multimedia release go to:
https://www.multivu.com/players/English/77126512-bayer-4-h-launch-science-matters/
Main goal of "Nomad Universe" is the preservation and revival of historical heritage and diversity of the original culture of peoples and ethnic groups worldwide. 1,000 participants from 90 countries will attend Nomad Universe to perform & present their cultural treasures in Art, Sport & Science.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8505551-ethnofestival-nomad-universe-in-riyadh/
Autism Speaks – the world’s leading autism science and advocacy organization – today joined the Ad Council and BBDO New York, the long-time volunteer agency for Autism Speaks, to announce the launch of a new series of public service advertisements (PSAs) designed to help parents recognize the early signs of autism and take immediate action. For the first time in the campaign’s history, the new PSAs feature an imaginative world, created using 3D and stop-motion animation, inspired by stories of real children with autism and told from the perspective of a child with autism. The PSAs are an extension of the award-winning “Learn the Signs” campaign, created by BBDO, which has helped significantly increase the percentage of parents who recognize the early warning signs of autism.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7674151-ad-council-autism-speaks-psa-s-2015/
A speaker for student or adult audiences, Joan Marie Galat delivers talks (in person or via
Skype) based on her award-winning books. She promotes literacy, science, dark skies, and
environmental appreciation. Joan encourages writers with talks on publishing and motivates
with keynotes based on her book: Give Yourself a Pep Talk. Find out more at www.moondotmedia.com Non-fiction/business/teaching/parents
Sanjay\\\'s research has been reviewed favorably by internationally reputed scientists. Some of his research has even appeared in international, peer-reviewed scientific journals. Sanjay\\\'s research on the new agreements between spirituality and science is the first ever to get published in such high-ranking journals. This is the gold standard in scientific research and a landmark of superb research on the subject of science and religion or science and spirituality. Visit http://www.SanjayCPatel.com
For the second straight year, Accenture (NYSE: ACN) is collaborating with Code.org to support Hour of Code, a global educational movement that reaches tens of millions of students through a one-hour introduction to computer science and computer programming.
As part of Accenture’s commitment to inspire and expand the opportunities for students to learn coding and computer science skills, Accenture employees in more than 200 cities across 55 countries have pledged to complete more than 10,000 Hours of Code during Computer Science Education Week December 5-11. This includes more than 2,000 hours pledged by Accenture employees to lead local events or volunteer at schools in their communities by working with teachers and Code.org to help students learn the basics of coding through online tutorials that inspire students to continue learning.
To view the multimedia release go to:
http://www.multivu.com/players/English/7993351-accenture-hour-of-code/
The Khaled bin Sultan Living Oceans Foundation launches a new website to illustrate their findings from one of the largest coral reef research projects ever conducted. The Foundation’s Global Reef Expedition is a six-year circumnavigation of the planet involving more than a hundred scientists from many nations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64379-khaled-bin-sultan-living-oceans-foundation-launches-new-website
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Don’t trust us, trust Science: Abbott is among the best science-based companies to work for in the world.
For the 13th consecutive year, the journal Science today recognized Abbott on its Top Employers list, evaluated on 23 characteristics including financial strength, easy adaptation to change and a having a research-driven environment.
”Abbott is unique in that we’ve been adding to our reservoir of scientific knowledge for 128 years,“ said John Frels, Ph.D., chair of Abbott’s Scientific Governing Board, which oversees the company’s senior scientific career track. ”We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today. This helps us to create new, breakthrough innovations that change people’s lives.“
To view the multimedia release go to:
http://www.multivu.com/players/English/7962251-science-names-abbott-2016-top-employer/
Eli Lilly and Company (NYSE: LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis.
Over 14 decades, the organization has contributed more than 100 medicines and significant medical advances, such as the first commercially available insulin, manufacturing and global distribution of the Salk polio vaccine and mental health breakthroughs such as anti-depressant Prozac® (fluoxetine). Today Lilly continues to progress its most robust pipeline in history with dozens of potential new medicines in mid- to late-stage development for cancer, diabetes, autoimmune disease, pain and Alzheimer’s disease.
“As Lilly celebrates 140 years, we’re keeping the vision of our founder alive – from our dedication in the lab to our impact in the community,” said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer, who began his career at Lilly as a chemist in 1979. “Colonel Eli Lilly started this company to put science to work fighting disease and encouraged his successors to ‘take what you find here and make it better and better.’ That vision pushes us daily to honor Colonel Lilly’s legacy and continue in our quest to discover new medicines to help make life better.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7809951-eli-lilly-and-company-140th-anniversary/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
